Stockscreener 앱 받기
2.18
0.00%
0.00
시간 외 거래:
2.18
전일 마감가:
$2.18
열려 있는:
$2.16
하루 거래량:
7,223
Relative Volume:
0.33
시가총액:
$6.74M
수익:
$4.33M
순이익/손실:
$-4.17M
주가수익비율:
-1.4579
EPS:
-1.4953
순현금흐름:
$-3.19M
1주 성능:
+4.81%
1개월 성능:
-0.46%
6개월 성능:
-30.13%
1년 성능:
-43.24%
1일 변동 폭
$2.125
$2.185
1주일 범위
$2.03
$2.22
52주 변동 폭
$1.8664
$4.60
Biomerica Inc Stock (BMRA) Company Profile
명칭
Biomerica Inc
전화
(949) 379-2875
주소
17571 VON KARMAN AVENUE, IRVINE, CA
Compare BMRA vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BMRA
Biomerica Inc
|
2.18 | 6.74M | 4.33M | -4.17M | -3.19M | -1.4953 |
ABT
Abbott Laboratories
|
96.00 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Biomerica Inc Stock (BMRA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-11-10 | 개시 | Colliers Securities | Buy |
| 2018-01-04 | 개시 | B. Riley FBR, Inc. | Buy |
Biomerica Inc 주식(BMRA)의 최신 뉴스
Biomerica Q3 Sales Fall, Net Loss Widens Amid Restructuring - Orange County Business Journal
Biomerica (BMRA) Secures Medicare Coverage for inFoods IBS Tests - GuruFocus
Biomerica, Inc. Receives Medicare Confirmation for inFoods® IBS Claims Processing Pathway - Quiver Quantitative
Biomerica Inc Announces Medicare Administrative Contractor Confirmation of Individual Claim Review For Infoods Ibs Test - marketscreener.com
Biomerica, Inc., Phoenix Airmid Biomedical And CanAlt Health Labs Launch inFoods IBS Platform In Canada - marketscreener.com
Biomerica reports net loss of USD 1.31M in Q3 2026 - Medical Buyer
Biomerica Launches inFoods® IBS in Canada Through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs - The Manila Times
Up to 5 million Canadians have IBS; Biomerica brings inFoods north - Stock Titan
Biomerica's Q3 revenue falls, net loss widens on lower manufacturing sales - TradingView
Biomerica Reports Third Quarter Fiscal 2026 Financial Results, Highlights Real-World Efficacy of inFoods® IBS and Growth in European Revenue - Quiver Quantitative
BRIEF-Biomerica Q3 Net Income USD -1.31 Million - TradingView
Biomerica IBS test gets $300 Medicare rate, reports pain relief - Stock Titan
Biomerica 10-Q: Revenue $0.99M, EPS $(0.44) for Q3 ended Feb 28, 2026 - TradingView
Biomerica (BMRA) revenue falls 22% as losses persist and going concern risk disclosed - Stock Titan
Biomerica, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2026 - marketscreener.com
Update Report: Will Biomerica Inc stock benefit from M A2026 Earnings Impact & Weekly Stock Breakout Alerts - baoquankhu1.vn
Aug Breakouts: Is Biomerica Inc a strong candidate for buy and holdMarket Volume Summary & Risk Controlled Daily Trade Plans - baoquankhu1.vn
Press Releases about Biomerica, Inc.Common Stock (Nasdaq:BMRA) - FinancialContent
Biomerica (BMRA) to Post Earnings on Monday - Defense World
BMRA: BiomericaInteractive Chart - Zacks Investment Research
BMRA Stock Price, Quote & Chart | BIOMERICA INC (NASDAQ:BMRA) - ChartMill
Should value investors consider Biomerica Inc2026 Price Targets & AI Enhanced Trade Execution Alerts - baoquankhu1.vn
AI Stocks: Whats the fair value of Biomerica Inc stockMarket Risk Report & Fast Gain Swing Alerts - baoquankhu1.vn
Rate Hike: What is the PEG ratio of Biomerica Inc2026 EndofYear Setup & Stock Portfolio Risk Management - baoquankhu1.vn
BMRA PE Ratio & Valuation, Is BMRA Overvalued - intellectia.ai
Biomerica gets first commercial order for H pylori test - MSN
Biomerica Receives First Commercial Order for its H. pylori test from one of the Largest Clinical Laboratory Chains in Europe - marketscreener.com
Biomerica (BMRA) Secures First European Order for H. pylori Test - GuruFocus
First European commercial order landed: US diagnostic product company Biomerica announces that its Helicobacter pylori detection product HP Detect™ has received the first commercial order from one of Europe's largest clinical laboratory chains. - Bitget
Biomerica Secures First Commercial Order for Hp Detect™ from Major European Laboratory Chain - Quiver Quantitative
Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect) from One of the Largest Clinical Laboratory Chains in Europe - Bitget
Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect™) from One of the Largest Clinical Laboratory Chains in Europe - marketscreener.com
Stomach cancer bacteria drives major lab’s first order of Hp Detect test - Stock Titan
Earnings Miss: Is Biomerica Inc stock a value trap2025 Top Decliners & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
Biomerica receives UK regulatory approval for H. pylori test - Investing.com
Biomerica receives UK regulatory approval for H. pylori test By Investing.com - Investing.com Nigeria
Biomerica (BMRA) Expands Market with UK Approval for hp+detect T - GuruFocus
Biomerica Receives MHRA Registration for hp+detect™, Allowing Commercial Sales in Great Britain - The Manila Times
Portfolio Recap: How does PSHG score in quality rankingsJuly 2025 Review & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Market Review: Can Biomerica Inc stock double in the next yearLayoff News & Weekly High Conviction Ideas - baoquankhu1.vn
Biomerica reports real-world IBS test results, Medicare rate set - Investing.com
Biometrica Down on Study - Baystreet.ca
Biomerica reports real-world IBS test results, Medicare rate set By Investing.com - Investing.com South Africa
Biomerica, Inc. Reports Successful Responder Analysis Results for inFoods® IBS and Establishes $300 Medicare Payment Rate - Quiver Quantitative
Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy - Weekly Voice
New finger-stick IBS test eases pain and bloating for most patients - Stock Titan
BMRA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Why Innovative Eyewear, Inc. stock attracts strong analyst attention - baoquankhu1.vn
BMRA Should I Buy - Intellectia AI
Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods IBS Therapy - Bitget
Biomerica (NASDAQ:BMRA) Stock Passes Below 200 Day Moving Average – Here’s Why - Defense World
Biomerica Inc (BMRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.74%
1.72%
자본화:
|
볼륨(24시간):